RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Ultrasound-guided drug delivery in cancer

      한글로보기

      https://www.riss.kr/link?id=A103555979

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Recent advancements in ultrasound and microbubble (USMB) mediated drug delivery technology has shown that this approach can improve spatially confined delivery of drugs and genes to target tissues while reducing systemic dose and toxicity. The mechani...

      Recent advancements in ultrasound and microbubble (USMB) mediated drug delivery technology has shown that this approach can improve spatially confined delivery of drugs and genes to target tissues while reducing systemic dose and toxicity. The mechanism behind enhanced delivery of therapeutics is sonoporation, the formation of openings in the vasculature, induced by ultrasound-triggered oscillations and destruction of microbubbles. In this review, progress and challenges of USMB mediated drug delivery are summarized, with special focus on cancer therapy.

      더보기

      참고문헌 (Reference)

      1 Zhao YZ, "Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo" 38 : 1090-1098, 2012

      2 Zhou S, "Ultrasoundtargeted microbubble destruction mediated herpes simplex virusthymidine kinase gene treats hepatoma in mice" 29 : 170-, 2010

      3 Boissenot T, "Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems:from theoretical considerations to practical applications" 241 : 144-163, 2016

      4 Carson AR, "Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy" 72 : 6191-6199, 2012

      5 Chen H, "Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors" 1 : 10-, 2013

      6 Bekeredjian R, "Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart" 108 : 1022-1026, 2003

      7 Yu BF, "Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma" 20 : 290-297, 2013

      8 Panje CM, "Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency" 2 : 1078-1091, 2012

      9 Schoellhammer CM, "Ultrasound-mediated gastrointestinal drug delivery" 7 : 310ra168-, 2015

      10 Mullick Chowdhury S, "Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs" 238 : 272-280, 2016

      1 Zhao YZ, "Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo" 38 : 1090-1098, 2012

      2 Zhou S, "Ultrasoundtargeted microbubble destruction mediated herpes simplex virusthymidine kinase gene treats hepatoma in mice" 29 : 170-, 2010

      3 Boissenot T, "Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems:from theoretical considerations to practical applications" 241 : 144-163, 2016

      4 Carson AR, "Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy" 72 : 6191-6199, 2012

      5 Chen H, "Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors" 1 : 10-, 2013

      6 Bekeredjian R, "Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart" 108 : 1022-1026, 2003

      7 Yu BF, "Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma" 20 : 290-297, 2013

      8 Panje CM, "Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency" 2 : 1078-1091, 2012

      9 Schoellhammer CM, "Ultrasound-mediated gastrointestinal drug delivery" 7 : 310ra168-, 2015

      10 Mullick Chowdhury S, "Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs" 238 : 272-280, 2016

      11 Wang TY, "Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer" 203 : 99-108, 2015

      12 Li P, "Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice" 162 : 349-354, 2012

      13 Abou-Elkacem L, "Ultrasound molecular imaging: moving toward clinical translation" 84 : 1685-1693, 2015

      14 Anderson CR, "Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent" 46 : 215-224, 2011

      15 Fokong S, "Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics" 53 : 345-348, 2012

      16 Ferrara K, "Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery" 9 : 415-447, 2007

      17 Azagury A, "Ultrasound effect on dancerous versus non-cancerous cells" 42 : 1560-1567, 2016

      18 Panje CM, "Ultrasound and microbubblemediated gene delivery in cancer: progress and perspectives" 48 : 755-769, 2013

      19 Tzu-Yin W, "Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications" 14 : 743-752, 2013

      20 Jürgen K. Willmann, "Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results" American Society of Clinical Oncology (ASCO) 35 (35): 2133-2140, 2017

      21 de Jong N, "Ultrasonic characterization of ultrasound contrast agents" 47 : 861-873, 2009

      22 Deshpande N, "Tumor angiogenic marker expression levels during tumor growth:longitudinal assessment with molecularly targeted microbubbles and US imaging" 258 : 804-811, 2011

      23 Kotopoulis S, "Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study" 40 : 072902-, 2013

      24 Bouakaz A, "Therapeutic ultrasound" Springer 175-189, 2016

      25 Escoffre JM, "Therapeutic ultrasound" Springer 243-261, 2016

      26 Rapoport N, "Therapeutic ultrasound" Springer 221-241, 2016

      27 Bettinger T, "Therapeutic ultrasound" Springer 191-204, 2016

      28 Tartis MS, "Therapeutic effects of paclitaxel-containing ultrasound contrast agents" 32 : 1771-1780, 2006

      29 Unger EC, "Therapeutic applications of lipid-coated microbubbles" 56 : 1291-1314, 2004

      30 Tsutsui JM, "The use of microbubbles to target drug delivery" 2 : 23-, 2004

      31 Husseini GA, "The role of cavitation in acoustically activated drug delivery" 107 : 253-261, 2005

      32 Pysz MA, "Targeted contrast-enhanced ultrasound:an emerging technology in abdominal and pelvic imaging" 140 : 785-790, 2011

      33 Willmann JK, "Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides" 51 : 433-440, 2010

      34 Sirsi SR, "State-of-the-art materials for ultrasoundtriggered drug delivery" 72 : 3-14, 2014

      35 Delalande A, "Sonoporation: mechanistic insights and ongoing challenges for gene transfer" 525 : 191-199, 2013

      36 Kotopoulis S, "Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft" 16 : 53-62, 2014

      37 Zhou Y, "Principles and applications of therapeutic ultrasound in healthcare" CRC Press 2015

      38 Paris JL, "Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers" 9 : 11023-11033, 2015

      39 Devulapally R, "Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy" 9 : 2290-2302, 2015

      40 Salgaonkar VA, "Passive cavitation imaging with ultrasound arrays" 126 : 3071-3083, 2009

      41 Coviello C, "Passive acoustic mapping utilizing optimal beamforming in ultrasound therapy monitoring" 137 : 2573-2585, 2015

      42 Yan F, "Paclitaxel-liposomemicrobubble complexes as ultrasound-triggered therapeutic drug delivery carriers" 166 : 246-255, 2013

      43 Chomas JE, "Optical observation of contrast agent destruction" 77 : 1056-1058, 2000

      44 Simonin JP, "On the mechanisms of in vitro and in vivo phonophoresis" 33 : 125-141, 1995

      45 Lv Y, "Novel multifunctional pHsensitive nanoparticles loaded into microbubbles as drug delivery vehicles for enhanced tumor targeting" 6 : 29321-, 2016

      46 Tinkov S, "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" 148 : 368-372, 2010

      47 Morch Y, "Nanoparticle-stabilized microbubbles for multimodal imaging and drug delivery" 10 : 356-366, 2015

      48 Lee JY, "Nanoparticle-loaded protein-polymer nanodroplets for improved stability and conversion efficiency in ultrasound imaging and drug delivery" 27 : 5484-5492, 2015

      49 Shapiro G, "Multiparameter evaluation of in vivo gene delivery using ultrasound-guided, microbubble-enhanced sonoporation" 223 : 157-164, 2016

      50 Deshpande N, "Molecular ultrasound imaging: current status and future directions" 65 : 567-581, 2010

      51 Pysz MA, "Molecular imaging: current status and emerging strategies" 65 : 500-516, 2010

      52 Willmann JK, "Molecular imaging in drug development" 7 : 591-607, 2008

      53 Kircher MF, "Molecular body imaging: MR imaging, CT, and US. Part II. Applications" 264 : 349-368, 2012

      54 Kircher MF, "Molecular body imaging: MR imaging, CT, and US. Part I. principles" 263 : 633-643, 2012

      55 Hernot S, "Microbubbles in ultrasound-triggered drug and gene delivery" 60 : 1153-1166, 2008

      56 Unnikrishnan S, "Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application" 199 : 292-299, 2012

      57 Sorace AG, "Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer" 20 : 43-54, 2012

      58 Vignon F, "Microbubble cavitation imaging" 60 : 661-670, 2013

      59 Kondo T, "Low-intensity ultrasound adjuvant therapy: enhancement of doxorubicin-induced cytotoxicity and the acoustic mechanisms involved" 36 : 61-, 2009

      60 Unger EC, "Local drug and gene delivery through microbubbles" 44 : 45-54, 2001

      61 Huang SL, "Liposomes in ultrasonic drug and gene delivery" 60 : 1167-1176, 2008

      62 Barnett SB, "International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine" 26 : 355-366, 2000

      63 Quinto-Su PA, "Interaction between two laser-induced cavitation bubbles in a quasi-two-dimensional geometry" 633 : 425-435, 2009

      64 Sonoda S, "Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization" 6 : 1276-1283, 2007

      65 Treat LH, "Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma" 38 : 1716-1725, 2012

      66 Mitragotri S, "Healing sound: the use of ultrasound in drug delivery and other therapeutic applications" 4 : 255-260, 2005

      67 Devulapally R, "Gemcitabine and antisense-microRNA co-encapsulated PLGA-PEG polymer nanoparticles for hepatocellular carcinoma therapy" 8 : 33412-33422, 2016

      68 Apfel RE, "Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound" 17 : 179-185, 1991

      69 Carlisle R, "Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound" 105 : 1701-1710, 2013

      70 Bai M, "Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound" 6 : 43779-43790, 2015

      71 Zhu F, "Effectiveness of localized ultrasoundtargeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model" 23 : 323-334, 2015

      72 Arora M, "Effect of nuclei concentration on cavitation cluster dynamics" 121 : 3432-3436, 2007

      73 Bachawal SV, "Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model" 73 : 1689-1698, 2013

      74 Lentacker I, "Drug loaded microbubble design for ultrasound triggered delivery" 5 : 2161-2170, 2009

      75 Cochran MC, "Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model" 18 : 1341-1348, 2011

      76 Caskey CF, "Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall" 122 : 1191-1200, 2007

      77 Tun MT, "Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts" 12 : 15-, 2012

      78 Foygel K, "Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1" 145 : 885-894, 2013

      79 Guan L, "Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities" 14 : 153-, 2016

      80 Borden MA, "DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles" 23 : 9401-9408, 2007

      81 Liu HL, "Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview" 4 : 432-444, 2014

      82 Blake JR, "Cavitation bubbles near boundaries" 19 : 99-123, 1987

      83 Lauterborn W, "Cavitation bubble dynamics" 4 : 65-75, 1997

      84 Wang DS, "Cationic versus neutral microbubbles for ultrasoundmediated gene delivery in cancer" 264 : 721-732, 2012

      85 Mukundakrishnan K, "Bubble motion in a blood vessel: shear stress induced endothelial cell injury" 131 : 074516-, 2009

      86 Liu HL, "Bloodbrain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment" 255 : 415-425, 2010

      87 Helfield B, "Biophysical insight into mechanisms of sonoporation" 113 : 9983-9988, 2016

      88 Kang J, "Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasoundtargeted microbubble activation on VX2 rabbit liver tumors" 29 : 61-70, 2010

      89 Pysz MA, "Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55)" 256 : 519-527, 2010

      90 Nie F, "Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: an in vivo experimental study" 16 : 389-395, 2008

      91 Tang H, "An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport" 19 : 1160-1169, 2002

      92 Unger EC, "Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent" 33 : 886-892, 1998

      93 Wilson KE, "Acoustic and photoacoustic molecular imaging of cancer" 54 : 1851-1854, 2013

      94 Wang XL, "A novel plasmid and SonoVue formulation plus ultrasound sonication for effective gene delivery in nude mice" 93 : 536-542, 2013

      95 Duan L, "A multi-gradient targeting drug delivery system based on RGD-L-TRAIL-labeled magnetic microbubbles for cancer theranostics" 26 : 8313-8324, 2016

      96 Dimcevski G, "A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer" 243 : 172-181, 2016

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2014-01-06 학술지명변경 한글명 : 대한초음파의학회지 -> ULTRASONOGRAPHY
      외국어명 : 미등록 -> ULTRASONOGRAPHY
      KCI등재
      2011-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-04-10 학회명변경 영문명 : Korean Society Of Medical Ultrasound -> Korean Society of Ultrasound in Medicine KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.33 0.33 0.23
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.17 0.13 0.599 0.18
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼